SNN

Q: What is the price of Smith & Nephew (SNN) today?

The current price of Smith & Nephew (SNN) is $ 33.49, representing a 34.75% gain over the past year. The stock began the year trading around $ 32.81 and is currently priced at $ 33.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Smith & Nephew (SNN) pay dividends?

Smith & Nephew (SNN) did not pay dividends over the past year.

Smith & Nephew PLC

Price

$ 33.49

return (12m)

34.75%

p/e

13.80

p/bv

2.71

DIVIDEND YIELD

2.29%

SNN price

SNN

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SNN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.14%

3 months

0.91%

1 year

34.75%

2 years

50.80%

5 years

-1.06%

10 years

23.06%

Fundamentals SNN

review the fundamentals of Smith & Nephew shares

P/E

13.80

Sector: -2.14 Industry: -5.42

P/S (PSR)

1.20

Sector: 1.94 Industry: 2.88

P/BV

2.71

Sector: 2.13 Industry: 2.09

DIVIDEND YIELD (DY)

2.29%

Sector: - Industry: -

ROA

9.92%

Sector: -25.39% Industry: -48.74%

ROE

19.61%

Sector: -29.75% Industry: -41.50%

ROIC

6.75%

Sector: -418.64% Industry: -484.72%

NET MARGIN

8.66%

Sector: -27.73% Industry: -32.27%

GROSS MARGIN

68.80%

Sector: 44.91% Industry: 45.26%

OPERATING MARGIN

12.12%

Sector: -22.84% Industry: -27.83%

EV/EBITDA

5.15

Sector: -0.35 Industry: -2.44

EV/EBIT

9.16

Sector: -1.68 Industry: -4.26

PRICE-TO-ASSETS

1.37

Sector: 1.14 Industry: 1.26

BVPS

12.30

Sector: 3.83 Industry: 2.16

EPS

2.41

Sector: -0.89 Industry: -1.33

EQUITY-TO-ASSETS RATIO

0.51

Sector: 0.44 Industry: 0.49

LIABILITIES / ASSETS

0.49

Sector: 0.46 Industry: 0.42

CAGR REVENUE 5 YEARS

18.10%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

31.67%

Sector: - Industry: -

FAIR VALUE OF Smith & Nephew ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 33.49

Fair Value

$ 0.00

Upside/Downside Return potential.

-22.89%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SNN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	41.59	35.99	86.53%	0.65%	$ 858.38 B	31.66%
ISRG	56.96	9.07	15.92%	0.00%	$ 162.68 B	28.38%
TMO	27.82	3.48	12.52%	0.35%	$ 186.54 B	15.05%
SNY	12.68	1.38	10.86%	4.67%	$ 115.62 B	18.68%
NVS	21.29	6.40	30.04%	4.48%	$ 297.73 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.58	2.30	9.38%	2.41%	$ 113.37 B	13.00%
GSK	15.39	5.50	35.71%	3.00%	$ 117.42 B	17.48%
CVS	56.86	1.33	2.35%	3.36%	$ 100.53 B	0.44%
BSX	31.39	0.00	0.00%	0.00%	$ 90.98 B	14.44%
TMDX	19.73	7.94	40.22%	0.00%	$ 3.75 B	31.43%
HCA	17.15	-41.99	-244.82%	0.58%	$ 116.34 B	8.97%
IDXX	44.22	29.19	65.99%	0.00%	$ 46.85 B	24.62%
RMD	22.49	5.29	23.51%	1.02%	$ 33.42 B	27.53%
DHR	38.03	2.62	6.88%	0.66%	$ 137.43 B	14.71%
INMD	9.25	1.27	13.73%	0.00%	$ 868.14 M	25.32%
PHG	25.94	2.09	8.06%	3.13%	$ 26.91 B	5.07%
FMS	11.96	0.81	6.75%	3.34%	$ 13.50 B	5.02%
SYK	40.02	5.79	14.48%	1.00%	$ 129.89 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

SNN Historical Dividends

current DY: 2.29%

5-year average DY: 2.78%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/27/2026	05/27/2026	0,47000000
Dividends	10/03/2025	11/07/2025	0,30000000
Dividends	03/28/2025	05/28/2025	0,46200000
Dividends	10/04/2024	11/08/2024	0,28800000
Dividends	04/02/2024	05/22/2024	0,46200000
Dividends	10/06/2023	11/01/2023	0,28800000
Dividends	03/31/2023	05/17/2023	0,46200000
Dividends	09/30/2022	10/26/2022	0,28800000
Dividends	04/01/2022	05/11/2022	0,46200000
Dividends	10/01/2021	10/27/2021	0,28800000
Dividends	04/06/2021	05/12/2021	0,46200000
Dividends	10/02/2020	10/28/2020	0,28800000
Dividends	04/03/2020	05/06/2020	0,46200000
Dividends	10/04/2019	10/30/2019	0,28800000
Dividends	04/05/2019	05/08/2019	0,44000000
Dividends	10/05/2018	10/31/2018	0,28000000
Dividends	04/06/2018	05/09/2018	0,45400000
Dividends	10/06/2017	11/01/2017	0,24600000
Dividends	03/31/2017	05/10/2017	0,37000000
Dividends	10/07/2016	10/25/2016	0,24600000
Dividends	04/22/2016	05/11/2016	0,38000000
Dividends	10/09/2015	10/27/2015	0,23600000
Dividends	04/17/2015	05/06/2015	0,37200000
Dividends	10/24/2014	11/11/2014	0,22000000
Dividends	04/22/2014	05/07/2014	0,34000000
Dividends	10/11/2013	10/29/2013	0,20800000
Dividends	04/19/2013	05/08/2013	0,32400000
Dividends	10/12/2012	10/30/2012	0,19800000
Dividends	04/20/2012	05/09/2012	0,21600000
Dividends	10/14/2011	11/01/2011	0,13200000
Dividends	05/03/2011	05/19/2011	0,19640000
Dividends	10/15/2010	11/02/2010	0,12000000
Dividends	04/23/2010	05/12/2010	0,17860000
Dividends	10/16/2009	11/03/2009	0,10920000
Dividends	04/17/2009	05/08/2009	0,16240000
Dividends	10/17/2008	11/07/2008	0,09920000
Dividends	04/18/2008	05/09/2008	0,14760000
Dividends	10/19/2007	11/09/2007	0,09020000
Dividends	04/20/2007	05/21/2007	0,13488000
Dividends	10/20/2006	11/10/2006	0,08200000
Dividends	04/21/2006	05/12/2006	0,12200000
Dividends	10/21/2005	11/21/2005	0,07300000
Dividends	04/22/2005	05/23/2005	0,11860000
Dividends	10/22/2004	11/22/2004	0,07000000
Dividends	04/23/2004	05/24/2004	0,10860000
Dividends	08/15/2003	09/22/2003	0,05890000
Dividends	04/22/2003	05/27/2003	0,10790000
Dividends	10/18/2002	11/25/2002	0,06310000
Dividends	04/19/2002	05/28/2002	0,09380000
Dividends	11/09/2001	12/17/2001	0,05530000
Dividends	04/20/2001	05/29/2001	0,08880000
Dividends	11/10/2000	12/18/2000	0,05410000

ABOUT Smith & Nephew

Smith & Nephew PLC

Average Investor10 user rating

4.0 (5 people)

United States

89 years

Founded: 1937

1999

Time since IPO - 27 years

17.637

Employees

Smith & Nephew PLC (United States) is listed on the NYSE and has a market capitalization of $14.31 Billions, with shareholders equity totaling $5.29 Billions.

The company employs approximately 17.637 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Smith & Nephew PLC reported $11.97 Billions in revenue, generating net income of $1.04 Billion.

Key financial metrics include a P/E ratio of 13.80, a price-to-book (P/B) ratio of 2.71, and a trailing twelve-month dividend yield of 2.29%.

The company trades under the ticker SNN.

Market cap

$ 14.31 Billions

Net worth

$ 5.29 Billions

$ 5,289,000,000.00

Assets

$ 10.46 Billions

$ 10,457,000,000.00

Total Shares Outstanding

430.00 Millions

430,000,000

Average Daily Trading Volume

$ 854.50 Thousand

$ 854,496.00

Sector

Health

Industry

Medical Supplies and Equipment

SNN

revenue by Business Segment Smith & Nephew

Revenue by Region Smith & Nephew

SNN revenue and profits

Financial Results SNN

DRAG THE FRAME TO SEE MORE DATA

SNN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.33 19,49% (12M)

P/E

56.86

3.36%

ROE

2.35%

P/BV

1.33

CI - Cigna

$ 271.25 --16,11% (12M)

P/E

10.78

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.30 --41,59% (12M)

P/E

-2.75

0.00%

ROE

-33.28%

P/BV

0.91

HUM - Humana

$ 192.15 --33,63% (12M)

P/E

19.94

1.79%

ROE

6.70%

P/BV

1.34

HCA - HCA Healthcare

$ 495.47 49,64% (12M)

P/E

17.15

0.58%

ROE

-244.82%

P/BV

-41.99

LLY - Eli Lilly

$ 939.47 25,45% (12M)

P/E

41.59

0.65%

ROE

86.53%

P/BV

35.99

NVS - Novartis

$ 153.96 51,25% (12M)

P/E

21.29

4.48%

ROE

30.04%

P/BV

6.40